These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review. Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199 [TBL] [Abstract][Full Text] [Related]
6. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection. Chen CC; Chang KC; Medeiros LJ; Lee JY Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496 [TBL] [Abstract][Full Text] [Related]
8. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites. Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668 [TBL] [Abstract][Full Text] [Related]
11. Clonal expansion of Epstein-Barr virus (EBV)-infected γδ T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions. Wada T; Toga A; Sakakibara Y; Toma T; Hasegawa M; Takehara K; Shigemura T; Agematsu K; Yachie A Int J Hematol; 2012 Oct; 96(4):443-9. PubMed ID: 22886572 [TBL] [Abstract][Full Text] [Related]
12. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites. Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411 [TBL] [Abstract][Full Text] [Related]
13. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells. Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296 [TBL] [Abstract][Full Text] [Related]
15. Characterization of skin blister fluids from children with Epstein-Barr virus-associated lymphoproliferative disease. Wada T; Toma T; Miyazawa H; Koizumi E; Shirahashi T; Matsuda Y; Yachie A J Dermatol; 2018 Apr; 45(4):444-449. PubMed ID: 29352500 [TBL] [Abstract][Full Text] [Related]
16. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721 [TBL] [Abstract][Full Text] [Related]
17. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation. Chen CC; Chang KC; Medeiros LJ; Lee JY J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667 [TBL] [Abstract][Full Text] [Related]
18. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953 [TBL] [Abstract][Full Text] [Related]
19. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases. Zhang Y; Liu Y; Xu J; Liang Y; Xu Z Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544 [TBL] [Abstract][Full Text] [Related]
20. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts. Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]